Ramya Thota

15PUBLICATIONS
78CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 15, 2026
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Apr 22, 2026
Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

|Feb 02, 2026
Bridging the Gap: Transforming Total Neoadjuvant Therapy: NEOTERIC Signals a Step Forward in the Treatment of Locally Advanced Rectal Cancer.

Christopher G Cann, Cathy Eng, Ramya Thota

|Jan 15, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Daniel R Carrizosa, Michael Rothe, Pam K Mangat

|Oct 16, 2025
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Tareq Al Baghdadi, Michael Rothe, Pam K Mangat

|Oct 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Francis P Worden, Evan Pisick, Michael Rothe

Pageof 3

Frequent Collaborators

13 joint publications

Elizabeth Garrett-Mayer

13 joint publications

Pam K Mangat

13 joint publications

Susan Halabi

13 joint publications

Gina N Grantham